Literature DB >> 12612469

Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.

D S Schauwecker1, A R Siddiqui, J D Wagner, D Davidson, S-H Jung, K A Carlson, G D Hutchins.   

Abstract

One hundred and nineteen patients with malignant melanoma were studied using 2-[ F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET). The images were reconstructed using ordered subset expectation maximization with and without attenuation correction and filtered backprojection with and without attenuation correction. The most probable draining lymph node chains were surgically explored and the tumour volume was quantified at histology. The four different reconstructions of the PET images were retrospectively graded on a five-point scale by two blind readers and compared with the tumour volume. The readers agreed within +/-1 grade 93% (529/568) of the time. Comparing the areas under the receiver operating characteristic (ROC) curves gave 0.698, 0.668, 0.694 and 0.684 for the four reconstruction techniques. The lowest value comparing any pair of the four reconstruction techniques was P=0.371. Thus, none of the reconstruction techniques gave significantly better results than any of the others. The sensitivity of detection was 85% for tumour volumes of 113 m or more (about 6 mm in diameter), but only 4% for tumours less than this size. It can be concluded that the use of attenuation correction gives aesthetically more pleasing images, but the sensitivity and specificity are not significantly improved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612469     DOI: 10.1097/00006231-200303000-00008

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.

Authors:  Christos Sachpekidis; Lionel Larribere; Leyun Pan; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss; Jessica C Hassel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-31       Impact factor: 9.236

2.  Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.

Authors:  Wouter V Vogel; Bart M Wensing; Jorn A van Dalen; Paul F M Krabbe; Frank J A van den Hoogen; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-16       Impact factor: 9.236

3.  Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.

Authors:  Janne Horn; Jørgen Lock-Andersen; Helle Sjøstrand; Annika Loft
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

4.  Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images.

Authors:  Anshika Bakshi; Saeid Gholami; Abass Alavi; Joel M Gelfand; Junko Takeshita
Journal:  Clin Nucl Med       Date:  2015-09       Impact factor: 7.794

5.  Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Authors:  Jacqueline Dinnes; Lavinia Ferrante di Ruffano; Yemisi Takwoingi; Seau Tak Cheung; Paul Nathan; Rubeta N Matin; Naomi Chuchu; Sue Ann Chan; Alana Durack; Susan E Bayliss; Abha Gulati; Lopa Patel; Clare Davenport; Kathie Godfrey; Manil Subesinghe; Zoe Traill; Jonathan J Deeks; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01

Review 6.  Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in oncology: a systematic review.

Authors:  Urvi Joshi; Pieter G H M Raijmakers; Ingrid I Riphagen; Gerrit J J Teule; Arthur van Lingen; Otto S Hoekstra
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.